Preclinical and Translational Sciences
Vibha Jawa, PhD, FAAPS
Executive Director
Non Clinical Development
Bristol Myers Squibb
Lawrenceville, New Jersey
Fei Hua, PhD
VP of Modeling and Simulation Services
Applied BioMath
Concord
Anant Madabhushi, PhD (he/him/his)
Professor
Emory University, Georgia
Michelle Graham, PhD (she/her/hers)
Principal Research Scientist
AbbVie
South San Francisco, California
Narendra Chirmule, Dr. (he/him/his)
CEO
SymphonyTech Biologucs
PHILADELPHIA, Pennsylvania
The use of ML-based algorithms, and training of systems to become artificially intelligent has become an essential part of medicine. The applications of these technologies range from drug discovery to managing the daily health of individuals. The panel discussion will focus on the use of AI/ML approaches to identify targets, delineate mechanisms of actions of efficacy, and predict toxicities. The topics will also include regulatory framework of the use of technology in drug development.